Sinopharm
1099.HK
#1870
Rank
โ‚ฌ8.31 B
Marketcap
2,66ย โ‚ฌ
Share price
-0.23%
Change (1 day)
21.13%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Sinopharm (1099.HK) - Total debt

Total debt on the balance sheet as of December 2023 : โ‚ฌ10.07 Billion

According to Sinopharm's latest financial reports the company's total debt is โ‚ฌ10.07 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Sinopharm - Total debt on balance sheet (from 2008 to 2023)

Total debt by year

Year Total debt Change
2022-12-31โ‚ฌ12.77 B34.84%
2021-12-31โ‚ฌ9.47 B10.91%
2020-12-31โ‚ฌ8.54 B21.23%
2019-12-31โ‚ฌ7.04 B0.6%
2018-12-31โ‚ฌ7.00 B46.8%
2017-12-31โ‚ฌ4.77 B4.03%
2016-12-31โ‚ฌ4.58 B12.21%
2015-12-31โ‚ฌ4.08 B4.49%
2014-12-31โ‚ฌ3.91 B30.02%
2013-12-31โ‚ฌ3.00 B53.72%
2012-12-31โ‚ฌ1.95 B15.34%
2011-12-31โ‚ฌ1.69 B334.45%
2010-12-31โ‚ฌ0.39 B122.37%
2009-12-31โ‚ฌ0.17 B2.37%
2008-12-31โ‚ฌ0.17 B-21.22%
2007-12-31โ‚ฌ0.21 B19.18%
2006-12-31โ‚ฌ0.18 B